In a recent study, Marczynski et al. [33] assessed the presence of the most frequent melanoma mutations, BRAF, NRAS, and TERT, in tumor samples from 19 advanced melanoma patients and tracked the mutations in plasma samples with digital PCR technology. This evidence concerns the gene BRAF and melanoma.